Cold & Cough Remedies - Hong Kong

  • Hong Kong
  • In Hong Kong, the revenue generated in the Cold & Cough Remedies market market reached US$319.40m in 2024.
  • It is projected that this market will experience an annual growth rate of 7.02% (CAGR 2024-2029).
  • When compared to other countries globally, the in the United States leads in terms of revenue, generating US$11,190.00m in 2024.
  • In relation to the population of Hong Kong, the per person revenue in the Cold & Cough Remedies market market amounted to US$42.60 in 2024.
  • Hong Kong's demand for innovative and natural cold & cough remedies is on the rise, driven by health-conscious consumers.

Key regions: United States, Japan, Australia, United Kingdom, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies market in Hong Kong has been experiencing steady growth in recent years, driven by customer preferences for over-the-counter (OTC) remedies and a rise in respiratory illnesses. Customer preferences in Hong Kong have shifted towards self-medication and convenience, leading to an increased demand for OTC cold and cough remedies. Consumers are increasingly seeking quick relief from symptoms such as coughing, congestion, and sore throat, and are willing to purchase over-the-counter products to alleviate their discomfort. This preference for self-medication is driven by factors such as convenience, cost-effectiveness, and the desire to avoid visiting a doctor for minor ailments. In addition to customer preferences, the growing prevalence of respiratory illnesses in Hong Kong has also contributed to the development of the Cold & Cough Remedies market. Factors such as air pollution, changing weather patterns, and a high population density have led to an increase in respiratory infections and allergies among the population. As a result, there is a higher demand for cold and cough remedies to manage these symptoms and provide relief. Trends in the market include the introduction of innovative products and formulations to cater to the specific needs of consumers. Manufacturers are focusing on developing remedies that target multiple symptoms and provide fast-acting relief. This includes products that combine cough suppressants, decongestants, and pain relievers to address a wide range of symptoms in one convenient dose. Additionally, there is a growing demand for natural and herbal remedies, as consumers are becoming more conscious of the ingredients they are putting into their bodies. Local special circumstances in Hong Kong also play a role in the development of the Cold & Cough Remedies market. The city's high population density and busy lifestyle contribute to the spread of respiratory infections, making cold and cough remedies a necessity for many individuals. Additionally, Hong Kong's healthcare system is known for its efficiency and accessibility, which encourages self-medication and the use of OTC remedies. Underlying macroeconomic factors, such as the growing middle class and increasing disposable income, have also contributed to the growth of the Cold & Cough Remedies market in Hong Kong. As more individuals have the means to afford healthcare products, the demand for OTC remedies has increased. Furthermore, the aging population in Hong Kong has led to a higher incidence of respiratory illnesses, driving the demand for cold and cough remedies even further. Overall, the Cold & Cough Remedies market in Hong Kong is developing due to customer preferences for self-medication and convenience, a rise in respiratory illnesses, the introduction of innovative products, local special circumstances, and underlying macroeconomic factors.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)